S
Susana Perez-Gutthann
Researcher at Pfizer
Publications - 71
Citations - 2608
Susana Perez-Gutthann is an academic researcher from Pfizer. The author has contributed to research in topics: Population & Cohort study. The author has an hindex of 24, co-authored 66 publications receiving 2209 citations. Previous affiliations of Susana Perez-Gutthann include Center for Medicine in the Public Interest & Johns Hopkins University.
Papers
More filters
Journal ArticleDOI
Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle–Ottawa Scale and the RTI item bank
Andrea V. Margulis,Manel Pladevall,Nuria Riera-Guardia,Cristina Varas-Lorenzo,Lorna Hazell,Nancy D. Berkman,Meera Viswanathan,Susana Perez-Gutthann +7 more
TL;DR: The RTI-IB facilitates a more complete quality assessment than the NOS but is more burdensome; the observed agreement and AC1 statistic in this study were higher than those reported by the RTI’s developers.
Journal ArticleDOI
Individual NSAIDs and Upper Gastrointestinal Complications: A Systematic Review and Meta-Analysis of Observational Studies (the SOS Project)
Jordi Castellsague,Nuria Riera-Guardia,Brian Calingaert,Cristina Varas-Lorenzo,Annie Fourrier-Réglat,Federica Nicotra,Miriam C. J. M. Sturkenboom,Susana Perez-Gutthann +7 more
TL;DR: In this article, the authors conducted a systematic review and meta-analysis of observational studies to provide summary relative risks (RR) of upper GI complications associated with the use of individual NSAIDs, including selective cyclooxygenase-2 inhibitors.
Journal ArticleDOI
Individual NSAIDs and Upper Gastrointestinal Complications
Jordi Castellsague,Nuria Riera-Guardia,Brian Calingaert,Cristina Varas-Lorenzo,Annie Fourrier-Réglat,Federica Nicotra,Miriam C. J. M. Sturkenboom,Susana Perez-Gutthann +7 more
TL;DR: In this paper, the authors conducted a systematic review and meta-analysis of observational studies to provide summary relative risks (RR) of upper GI complications (UGIC) associated with the use of individual NSAIDs, including selective cyclooxygenase-2 inhibitors.
Journal ArticleDOI
Morbidity of systemic lupus erythematosus: role of race and socioeconomic status
TL;DR: The data fail to support an independent association of black race with morbidity in SLE; rather, they suggest that noncompliance (as measured by physician global assessment) and type of medical insurance are important factors in morbidity.
Journal ArticleDOI
Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan.
Choitsu Sakamoto,Kentaro Sugano,Shinichi Ota,Nobuhiro Sakaki,Shin'ichi Takahashi,Yukio Yoshida,Taku Tsukui,Hiroyuki Osawa,Yukihiro Sakurai,Junji Yoshino,Yuji Mizokami,Tetsuya Mine,Tetsuo Arakawa,Hajime Kuwayama,Katsunori Saigenji,Koji Yakabi,Tsutomu Chiba,Tooru Shimosegawa,Jane E. Sheehan,Susana Perez-Gutthann,Takuhiro Yamaguchi,David Kaufman,Tsugumichi Sato,Kiyoshi Kubota,Akira Terano +24 more
TL;DR: NSAIDs including loxoprofen increase the risk of UGIB in Japan as in Western countries, with a similar magnitude of association, and there was no evidence of biological interaction between NSAIDs and H. pylori infection.